Sobhi M. Gomha
Sobhi M. Gomha publishes mostly in Organic Chemistry, Molecular Biology and Materials Chemistry, on topics such as Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds and Multicomponent Synthesis of Heterocycles.
- World rank
- #338,724 of 7,710,434 ranked researchers
- Rank in Egypt
- #833 of 36,277
- Works
- 397
- Citations
- 8.4k
- Citations per work
- 21.1
What does Sobhi M. Gomha research?
Sobhi M. Gomha's work is mostly in Chemistry (70%), Materials Science (6%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences31880.2%
- Chemistry27669.6%
- Materials Science225.5%
- Computer Science123.0%
- Engineering82.1%
- Everything else6215.7%
- Life Sciences164.1%
- 1Organic Chemistry70% of their works
- 2Molecular Biology4% of their works
- 3Materials Chemistry3% of their works
- 4Computational Theory and Mathematics3% of their works
- 5Electronic, Optical and Magnetic Materials2% of their works
- 6Electrical and Electronic Engineering2% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Multicomponent Synthesis of Heterocycles
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
- Computational Drug Discovery Methods
- Quinazolinone synthesis and applications
- Synthesis and Reactivity of Heterocycles
Which keywords describe Sobhi M. Gomha's research?
The keywords of their largest research topics: Medicinal Chemistry, Heterocyclic Compounds, Anticancer Agents, Drug Discovery, Biological Evaluation, Synthesis, Tubulin Inhibitors and Vascular Targeting Agents.
- Indolizines
- Quinazoline
- Virtual Screening
- Copper-Catalyzed Cycloaddition
- Quinoxaline
- Multicomponent Reactions
- Antimicrobial Activity
- Scaffold
- Anticancer
- Vascular Targeting Agents
- Synthesis
- Drug Discovery
- Heterocyclic Compounds
- Medicinal Chemistry
- Anticancer Agents
- Biological Evaluation
- Tubulin Inhibitors
- Molecular Docking
- Antimicrobial
- Triazines
- Green Chemistry
- Derivatives
- Click Chemistry
- Drug Target Identification
- Indirubin
- Bioactivity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Medicinal Chemistry3683 topics
- Heterocyclic Compounds3513 topics
- Anticancer Agents3342 topics
- Drug Discovery3013 topics
- Biological Evaluation2714 topics
- Synthesis2714 topics
- Tubulin Inhibitors2561 topic
- Vascular Targeting Agents2561 topic
- Molecular Docking2023 topics
- Anticancer1762 topics
- Antimicrobial1762 topics
- Scaffold1511 topic
- Triazines1511 topic
- Antimicrobial Activity952 topics
- Green Chemistry881 topic
- Multicomponent Reactions881 topic
- Derivatives781 topic
- Quinoxaline781 topic
- Click Chemistry621 topic
- Copper-Catalyzed Cycloaddition621 topic
- Drug Target Identification341 topic
- Virtual Screening341 topic
- Indirubin251 topic
- Quinazoline251 topic
- Bioactivity171 topic
- Indolizines171 topic
Where does Sobhi M. Gomha work?
Sobhi M. Gomha's main affiliation in the publication record is Cairo University, Egypt.
How many publications and citations does Sobhi M. Gomha have?
OpenAlex counts 397 works and 8,376 citations for Sobhi M. Gomha, an h-index of 51, ranking #338,724 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sobhi M. Gomha. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.